Angiogenetic tissue in a number of tumors, like breast cancer, prostate cancer, kidney cancer, liver cancer, and other tumors, overexpresses prostate-specific membrane antigen (PSMA) [7,16]. This evidence concerns the gene FOLH1 and liver cancer.